Bioventus Pfcf Ratio from 2010 to 2024

BVS Stock  USD 11.71  0.20  1.74%   
Bioventus PFCF Ratio yearly trend continues to be comparatively stable with very little volatility. PFCF Ratio is likely to outpace its year average in 2024. From the period from 2010 to 2024, Bioventus PFCF Ratio quarterly data regression had r-value of  0.80 and coefficient of variation of (231.00). View All Fundamentals
 
PFCF Ratio  
First Reported
2010-12-31
Previous Quarter
41.36214101
Current Value
43.43
Quarterly Volatility
155.23721832
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.7 M, Interest Expense of 42.7 M or Total Revenue of 386.8 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 4.0E-4 or PTB Ratio of 1.81. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.
  
Check out the analysis of Bioventus Correlation against competitors.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

Latest Bioventus' Pfcf Ratio Growth Pattern

Below is the plot of the Pfcf Ratio of Bioventus over the last few years. It is Bioventus' PFCF Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bioventus' overall financial position and show how it may be relating to other accounts over time.
Pfcf Ratio10 Years Trend
Slightly volatile
   Pfcf Ratio   
       Timeline  

Bioventus Pfcf Ratio Regression Statistics

Arithmetic Mean(67.20)
Geometric Mean64.03
Coefficient Of Variation(231.00)
Mean Deviation138.10
Median27.31
Standard Deviation155.24
Sample Variance24,099
Range389
R-Value0.80
Mean Square Error9,391
R-Squared0.64
Significance0.0004
Slope27.73
Total Sum of Squares337,380

Bioventus Pfcf Ratio History

2024 43.43
2023 41.36
2022 -6.39
2021 55.24
2020 21.35
2019 33.72

About Bioventus Financial Statements

Bioventus shareholders use historical fundamental indicators, such as Pfcf Ratio, to determine how well the company is positioned to perform in the future. Although Bioventus investors may analyze each financial statement separately, they are all interrelated. The changes in Bioventus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioventus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
PFCF Ratio 41.36  43.43 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.